Furthermore, PEPCK1 overexpression partially abolished the protective effect of TRIM21 overexpression on HFD-induced hepatosteatosis, insulin resistance, and glucose intolerance, consistent with PEPCK1 function in gluconeogenesis. The gene discussed is PCK1; the disease is Insulin resistance.